You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Drug Therapy, Other

Citations 81-90 of 172 total displayed.

Past content (since Feb 1998):

Clinical Sciences
Evaluation of Topical Cyclosporine for the Treatment of Dry Eye Disease
Henry D. Perry; Renée Solomon; Eric D. Donnenfeld; Alicia R. Perry; John R. Wittpenn; Herb E. Greenman; Howard E. Savage
Arch Ophthalmol 2008; 126: 1046-1050. [Abstract] [Full text] [PDF]  

Laboratory Sciences
Suppression of Retinal Neovascularization With an Antagonist to Vascular Endothelial Cadherin
Deepti Navaratna; Joann Maestas; Paul G. McGuire; Arup Das
Arch Ophthalmol 2008; 126: 1082-1088. [Abstract] [Full text] [PDF]  

Editorials
AIDS and Ophthalmology, 2008
Douglas A. Jabs
Arch Ophthalmol 2008; 126: 1143-1146. [Extract] [Full text] [PDF]  

Small Case Series
Toxoplasmosis-Associated Neovascular Lesions Treated Successfully With Ranibizumab and Antiparasitic Therapy
Joseph D. Benevento; Rama D. Jager; A. Gwendolyn Noble; Paul Latkany; William F. Mieler; Mari Sautter; Sanford Meyers; Marilyn Mets; Michael A. Grassi; Peter Rabiah; Kenneth Boyer; Charles Swisher; Rima McLeod; for the Toxoplasmosis Study Group
Arch Ophthalmol 2008; 126: 1152-1156. [Extract] [Full text] [PDF]  

Small Case Series
Functional Use of Hyaluronic Acid Gel in Lower Eyelid Retraction
Maryam Zamani; Sri Thyagarajan; Jane M. Olver
Arch Ophthalmol 2008; 126: 1157-1159. [Extract] [Full text] [PDF]  

Research Letters
Intravitreous Bevacizumab as Anti–Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study
Lingkun Kong; Helen A. Mintz-Hittner; Rebecca L. Penland; Francis L. Kretzer; Patricia Chévez-Barrios
Arch Ophthalmol 2008; 126: 1161-1163. [Extract] [Full text] [PDF]  

Clinical Sciences
Bevacizumab Treatment for Subfoveal Choroidal Neovascularization From Causes Other Than Age-Related Macular Degeneration
Louis K. Chang; Richard F. Spaide; Claudia Brue; K. Bailey Freund; James M. Klancnik Jr; Jason S. Slakter
Arch Ophthalmol 2008; 126: 941-945. [Abstract] [Full text] [PDF]  

Laboratory Sciences
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Mark H. Criswell; Wen-Zheng Hu; Timothy J. Steffens; Ruihong Li; Philippe Margaron
Arch Ophthalmol 2008; 126: 946-952. [Abstract] [Full text] [PDF]  

Laboratory Sciences
Inhibitory Effect of Bevacizumab on the Angiogenesis and Growth of Retinoblastoma
Sun Young Lee; Dong-Kyu Kim; Jae Hyung Cho; Jae-Young Koh; Young Hee Yoon
Arch Ophthalmol 2008; 126: 953-958. [Abstract] [Full text] [PDF]  

Ophthalmic Molecular Genetics
Intraocular Pressure Response to Topical β-Blockers Associated With an ADRB2 Single-Nucleotide Polymorphism
Catherine A. McCarty; James K. Burmester; Bickol N. Mukesh; Richard B. Patchett; Russell A. Wilke
Arch Ophthalmol 2008; 126: 959-963. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Drug Therapy, Other
 collections from JAMA & Archives Journals.
 •Related collections:
  •Drug Therapy
  •Adherence
  •Adverse Effects
  •Medication Error
  •Pediatric Dosing
  •Drug Therapy, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.